| Financial Year |
March 31 2023 |
| Monetary Funds |
507,386,346.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,631,812.59 |
| Accounts Receivable |
72,534,271.00 |
| Advances to Suppliers |
6,370,617.58 |
| Other Receivables |
1,038,322.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,078,356.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,663,716.46 |
| Total Current Assets |
698,837,684.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
339,601,337.56 |
| Under-construction Projects |
142,949,295.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
80,113,568.61 |
| R&D expenses |
-- |
| Goodwill |
124,972.13 |
| Long-Term Deferred and Prepaid Expenses |
404,311.68 |
| Deferred Income Tax Assets |
3,987,387.73 |
| Other Non-Current Assets |
5,423,643.25 |
| Sub-Total of Non-Current Assets |
573,540,776.54 |
| Total Assets |
1,272,378,460.72 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
44,962,733.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,602,536.22 |
| Taxes Payable |
1,188,213.24 |
| Interest Payable |
-- |
| Dividend Payable |
119,013.20 |
| Other payables |
8,139,126.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
998,726.08 |
| Other Current Liabilities |
5,867,478.44 |
| Sub-Total of Current Liabilities |
107,775,547.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,097,449.00 |
| Total Liabilities |
133,872,996.56 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
674,915,242.21 |
| Surplus Reserve |
40,141,906.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
318,860,965.29 |
| Minority Stockholder's Interest |
6,988,648.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,131,516,815.59 |
| Owner's Equity（Stockholder's Equity） |
1,138,505,464.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,272,378,460.72 |
